id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-0248-0005,FDA,FDA-2022-E-0248,Letter from FDA CDER to U S Patent TradeMark Office,Other,Letter(s),2024-01-22T05:00:00Z,2024,1,2024-01-22T05:00:00Z,,2024-01-22T17:46:03Z,,0,0,09000064863ae2a4